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Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disorder 
due to the deficiency of -L-iduronidase (IDUA). Severely affected 
patients show coarse faces, hepatosplenomegaly and mental 
retardation. Mild cases have facial features, joint stiffness, short 
stature but no CNS involvement. The gene encoding IDUA was 
cloned in 1990 and more than 55 disease-causing mutations have been 
described so far. Mutation frequency varies worldwide but W402X is 
the most frequent mutation found in European patients. 
A group of 56 MPS I patients, 25 from Argentina and 31 from Brazil, 
were genotyped. By analyzing ten recurrent mutations we were able to 
define 76% of the Argentinean alleles and 60% of the genotypes. For 
the Brazilian group, 62% of the alleles and 45% of the genotypes were 
assigned by the analysis of these same ten mutations. Sequencing of 
Brazilian patients led to the discovery of 13 new mutations and 4 new 
ones were found in Argentineans. 
The two most frequent mutations in both populations were W402X 
and P533R. The number of alleles bearing private mutations in 
Argentinean patients was 3 out of 50 and among the Brazilians, 16 out 
of 58. Such genetic heterogeneity is a concern when analyzing 
patients from miscigenated populations, such as South American 
countries.  
